Funding for this research was provided by:
Eli Lily and Co.
Daiichi Sankyo Inc.
Text and Data Mining valid from 2019-03-28
First Online: 28 March 2019
Compliance with ethical standards
: We have the following financial disclosures to report: Dr. Mehran has received institutional grant support from The Medicines Company, Bristol-Myers Squibb/Sanofi, and Eli Lilly and Company/Daiichi Sankyo; and is a consultant to Abbott Vascular, AstraZeneca, Boston Scientific, Covidien, Janssen Pharmaceuticals, Regado Biosciences, Maya Medical, Merck & Co., and The Medicines Company. Dr. Kini serves on the speaker’s bureau of the ACC and has received consulting fees from WebMD. Dr. Henry has received research grant support from Eli Lilly and company, and Daiichi Sankyo. Mr. Keller is employed by Eli Lilly and Company and Dr. Effron is a shareholder and retiree of Eli Lilly and Company. Dr. Baker is employed by Daiichi Sankyo, Inc. All other authors report no relevant conflicts of interest.